Showing results (91-100 of 131) with videos related to

Sort By:
Pageof 14
Cellular & Molecular Immunology|January 7, 2021
Dynamic immune profiling identifies the stronger graft-versus-leukemia (GVL) effects with haploidentical allografts compared to HLA-matched stem cell transplantationHuidong Guo, Ying-Jun Chang, Yan Hong, et al.
Bone Marrow Transplantation|May 10, 2020
Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibodyYing-Jun Chang, Lan-Ping Xu, Yu Wang, et al.
Leukemia & Lymphoma|February 10, 2016
Combined model of the EBMT score modified model and the HCT-CI improves the stratification of high-risk patients undergoing unmanipulated haploidentical blood and marrow transplantationYing-Jun Chang, Hong-Tao Wang, Lan-Ping Xu, et al.
BMC Medicine|April 25, 2024
Mini-dose methotrexate combined with methylprednisolone for the initial treatment of acute GVHD: a multicentre, randomized trialYu Wang, Qi-Fa Liu, De-Pei Wu, et al.
Bone Marrow Transplantation|February 13, 2025
The haematopoietic cell transplantation comorbidity index predicts clinical outcomes for severe aplastic anaemia patients after haploidentical haematopoietic stem cell transplantationMing-Hao Lin, Xiao-Jun Huang, Lan-Ping Xu, et al.
Bone Marrow Transplantation|August 23, 2025
Leukemia stem cells for relapse prediction in AML patients receiving allografts: long-term follow-up of a prospective studySi-Qi Li, Lan-Ping Xu, Yu Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 12, 2018
Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor EraYu-Juan Xue, Yi-Fei Cheng, Ai-Dong Lu, et al.
Bone Marrow Transplantation|January 19, 2019
Class I and II human leukocyte antibodies in pediatric haploidentical allograft candidates: prevalence and risk factorsMeng Lv, Shu-Zhen Zhai, Yu Wang, et al.
Clinical Transplantation|November 22, 2020
The incidence, clinical outcome, and protective factors of mixed chimerism following hematopoietic stem cell transplantation for severe aplastic anemiaZheng-Li Xu, Yi-Fei Cheng, Yuan-Yuan Zhang, et al.
Journal of Hematology & Oncology|March 20, 2019
Early myeloid-derived suppressor cells (HLA-DR-/lowCD33+CD16-) expanded by granulocyte colony-stimulating factor prevent acute graft-versus-host disease (GVHD) in humanized mouse and might contribute to lower GVHD in patients post allo-HSCTKe Wang, Meng Lv, Ying-Jun Chang, et al.
Pageof 14